Abstract:Background D‐dimer is involved in poor outcomes of stroke as a coagulation biomarker. We aimed to investigate the associations of the level and increase in D‐dimer between baseline and 90 days with all‐cause death or poor functional outcome in patients after ischemic stroke or transient ischemic attack. Methods and Results We collected data from the CNSRIII (Third China National Stroke Registry) study. The present substudy included 10 518 patients within 7 days (baseline) of ischemic stroke or transient ischemic attack and 6268 patients at 90 days. Poor functional outcome at 1 year was assessed on the basis of the modified Rankin Scale (≥3). Multivariable Cox regression or logistic regression was used to assess the association of D‐dimer levels with all‐cause death or poor functional outcome. D‐dimer levels at 90 days were lower than those at baseline (1.4 μg/mL versus 1.7 μg/mL; P <0.001). Higher baseline D‐dimer level was associated with all‐cause death (adjusted hazard ratio [HR], 1.77; 95% CI, 1.25–2.52; P =0.001) and poor functional outcome (adjusted odds ratio [OR], 1.49; 95% CI, 1.23–1.80; P <0.001) during 1‐year follow‐up. Higher D‐dimer level at 90 days was also associated with poor outcomes independently. Furthermore, an increase in D‐dimer levels between baseline and 90 days was associated with all‐cause death (since 90 days to 1 year after index event) (adjusted HR, 1.99; 95% CI, 1.12–3.53; P =0.019) but not with poor functional outcome (adjusted OR, 1.08; 95% CI, 0.82–1.41). Conclusions Our study shows that high level and an increase in D‐dimer between baseline and 90 days are associated with poor outcomes in patients after ischemic stroke or transient ischemic attack. Nonstandard Abbreviations and Acronyms CNSRIII Third China National Stroke Registry mRS modified Rankin Scale NIHSS National Institutes of Health Stroke Scale TOAST Trial of Org 10172 in Acute Stroke Treatment Clinical Perspective What Is New? Baseline and 90‐day D‐dimer levels were associated with all‐cause death and poor functional outcome in a large population with ischemic stroke or transient ischemic attack. An increase in D‐dimer levels was associated with all‐cause death after ischemic stroke or transient ischemic attack. What Are the Clinical Implications? Dynamic measurements of D‐dimer levels might be helpful for identifying patient with stroke or transient ischemic attack at a higher risk of recurrent events. It is uncertain if patients with stroke or transient ischemic attack and an elevated D‐dimer may benefit from more aggressive antithrombotic or anticoagulant measures for secondary stroke prevention. Cerebrovascular disease is the leading cause of death and disability in China, with the majority of cases (69.6%–70.8%) involving ischemic stroke and transient ischemic attack (TIA). 1 , 2 Identifying potential risk factors of poor outcomes and developing targeted therapeutics are critical. In particular, we recently reported that lipid metabolism and inflammatory factors were associated with stroke outcomes. 3 , 4 , 5 D‐dimer, which is a fibrin degradation product, is a biomarker for coagulation and reflects increased thrombosis. 6 , 7 Although D‐dimer level has been clearly confirmed to be associated with death in the general population in the long term, 8 , 9 only a few studies assessed the association of D‐dimer with death 10 , 11 , 12</s -Abstract Truncated-

Post-Treatment Plasma D-Dimer Levels Are Associated With Short-Term Outcomes in Patients With Cancer-Associated Stroke

Elevated plasma D-dimer levels are associated with short-term poor outcome in patients with acute ischemic stroke: a prospective, observational study

High D-dimer levels are associated with poor prognosis in cancer patients

Plasma D-Dimer Predicts Short-Term Poor Outcome after Acute Ischemic Stroke

Impact of D-dimer on the outcomes of endovascular thrombectomy for acute ischemic stroke: A systematic review and meta-analysis

The D-dimer level predicts the postoperative prognosis in patients with non-small cell lung cancer

Association of Level and Increase in D-Dimer With All-Cause Death and Poor Functional Outcome After Ischemic Stroke or Transient Ischemic Attack.

A Systematic Review of the Predictive Value of Plasma D-Dimer Levels for Predicting Stroke Outcome

High pretreatment plasma D-dimer levels are related to shorter overall survival in endometrial carcinoma

Effects of Plasma D-dimer Levels on Early Mortality and Long-Term Functional Outcome after Spontaneous Intracerebral Hemorrhage.

Plasma D‐dimer Predicts Poor Outcome and Mortality after Spontaneous Intracerebral Hemorrhage

High plasma D-dimer levels correlate with ictal infarction and poor outcomes in spontaneous subarachnoid hemorrhage

Abstract WP237: Anticoagulant Utilization and Risk of Thromboembolic Events Following Ischemic Stroke Among Adults With Cancer

Prognostic role of early D-dimer level in patients with acute ischemic stroke.

Elevated D-Dimer Levels Correlate with the Development of Hepatorenal Syndrome and a Poor Outcome in Patients with Cirrhosis

Association of D-dimer level with thrombotic events, bleeding, and mortality in Japanese patients with solid tumors: a Cancer-VTE Registry subanalysis

Diagnosing cancer-associated ischemic stroke: A systematic review of hematological biomarkers

The Significance of the D-Dimer Level as a Prognostic Marker for Survival and Treatment Outcomes in Patients With Stage IV Colorectal Cancer

Direct Oral Anticoagulants vs. Heparin for Cancer-Related Stroke: Augmented Meta-Analysis

Elevated Level of D-dimer Increases the Risk of Stroke

D-dimer and diffusion-weighted imaging pattern as two diagnostic indicators for cancer-related stroke: A case-control study based on the STROBE guidelines.